Hancock Jaffe Laboratories Inc (HJLI) Stock Price, Quote, News and Overview
NASDAQ:HJLI - Nasdaq -
HJLI Quote, Performance and Key Statistics
10.38
-0.21 (-1.98%)
The current stock price of HJLI is 10.38 null. In the past month the price increased by 33.76%. In the past year, price decreased by -3.67%.
HJLI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.9 | 222.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 74.08 | 202.84B | ||
| BSX | BOSTON SCIENTIFIC CORP | 38.13 | 152.27B | ||
| SYK | STRYKER CORP | 30.83 | 147.45B | ||
| MDT | MEDTRONIC PLC | 15.78 | 108.05B | ||
| BDX | BECTON DICKINSON AND CO | 12.14 | 49.11B | ||
| EW | EDWARDS LIFESCIENCES CORP | 29.52 | 45.12B | ||
| IDXX | IDEXX LABORATORIES INC | 44.69 | 41.28B | ||
| RMD | RESMED INC | 27.2 | 36.22B | ||
| DXCM | DEXCOM INC | 52.44 | 33.93B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.83 | 33.35B | ||
| PODD | INSULET CORP | 88.79 | 22.61B |
Related stock screener links
About HJLI
Company Profile
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 19 full-time employees. The company went IPO on 2018-05-31. The firm is engaged in developing tissue based devices that are designed for patients with cardiovascular disease, and peripheral arterial and venous disease. The firm's product includes VenoValve and CoreoGraft. VenoValve is a device surgically implanted in the deep venous system of the leg to treat a debilitating condition called chronic venous insufficiency (CVI). CoreoGraft is a bovine based conduit to be used to revascularize the heart during coronary artery bypass graft (CABG) surgeries.
Company Info
Hancock Jaffe Laboratories Inc
70 Doppler
Irvine CALIFORNIA 92618 US
CEO: Robert Berman
Employees: 19
Phone: 19492612900.0
Hancock Jaffe Laboratories Inc / HJLI FAQ
What is the stock price of Hancock Jaffe Laboratories Inc today?
The current stock price of HJLI is 10.38 null. The price decreased by -1.98% in the last trading session.
What is the ticker symbol for Hancock Jaffe Laboratories Inc stock?
The exchange symbol of Hancock Jaffe Laboratories Inc is HJLI and it is listed on the Nasdaq exchange.
On which exchange is HJLI stock listed?
HJLI stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for Hancock Jaffe Laboratories Inc stock?
1 analysts have analysed HJLI and the average price target is 26.52 null. This implies a price increase of 155.49% is expected in the next year compared to the current price of 10.38. Check the Hancock Jaffe Laboratories Inc stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is Hancock Jaffe Laboratories Inc worth?
Hancock Jaffe Laboratories Inc (HJLI) has a market capitalization of 90.15M null. This makes HJLI a Micro Cap stock.
How many employees does Hancock Jaffe Laboratories Inc have?
Hancock Jaffe Laboratories Inc (HJLI) currently has 19 employees.
What are the support and resistance levels for Hancock Jaffe Laboratories Inc (HJLI) stock?
Hancock Jaffe Laboratories Inc (HJLI) has a support level at 6.48. Check the full technical report for a detailed analysis of HJLI support and resistance levels.
Should I buy Hancock Jaffe Laboratories Inc (HJLI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of HJLI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of HJLI, evaluating the profitability, health, valuation and growth aspects
- Hancock Jaffe Laboratories Inc (HJLI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Hancock Jaffe Laboratories Inc (HJLI) Sales and EPS estimates to see what analysts future expectations are.
- Hancock Jaffe Laboratories Inc (HJLI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Hancock Jaffe Laboratories Inc (HJLI) Insider and Institutional Ownership to learn about the owners and their transactions.
- Hancock Jaffe Laboratories Inc (HJLI) Stock Chart to make your own analysis
- Hancock Jaffe Laboratories Inc (HJLI) Latest news and press-releases to stay up to date.
Does Hancock Jaffe Laboratories Inc (HJLI) stock pay dividends?
HJLI does not pay a dividend.
When does Hancock Jaffe Laboratories Inc (HJLI) report earnings?
Hancock Jaffe Laboratories Inc (HJLI) will report earnings on 2022-03-01, after the market close.
What is the Price/Earnings (PE) ratio of Hancock Jaffe Laboratories Inc (HJLI)?
Hancock Jaffe Laboratories Inc (HJLI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.47).
HJLI Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to HJLI. When comparing the yearly performance of all stocks, HJLI is one of the better performing stocks in the market, outperforming 77.04% of all stocks.
HJLI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to HJLI. HJLI has a great financial health rating, but its profitability evaluates not so good.
HJLI Financial Highlights
Over the last trailing twelve months HJLI reported a non-GAAP Earnings per Share(EPS) of -4.47. The EPS increased by 48.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -27.15% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
HJLI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 100% to HJLI. The Buy consensus is the average rating of analysts ratings from 1 analysts.